Revvity Naloxone, -

Revvity Naloxone functions as a non-selective, competitive antagonist at opioid receptors. It commonly used to reverse the effects of opioid overdose and to prevent opioid abuse. - REVPFZ (Additional S&H Or Hazmat Fees May Apply)

Revvity We offer both agonist and antagonist radioligands for autoradiographic visualization or performing saturation and competition assays to determine receptor expression levels (B_max), dissociation constants (K_d), association and dissociation rates (k_on and k_off), and inhibitor constants (K_i) for a variety of receptors. We develop our radioligands to the highest specific activity possible and provide high purity resulting in low non-specific binding products. Each of our ultra-pure radioligands is fully characterized for pharmacological action and validated in receptor binding assays. - REVPFZ (Additional S&H Or Hazmat Fees May Apply)

Revvity Radiolabeled ligands remain the most sensitive method for probing receptor binding biology; yielding unprecedented sensitivity gives results that technicians and scientists can trust. For over 50 years, Revvity has been a leading supplier of New England Nuclear (NEN) radiochemicals, liquid scintillation cocktails, vials and nuclear counting detection instruments. - REVPFZ (Additional S&H Or Hazmat Fees May Apply)

Revvity References for NET719: - REVPFZ (Additional S&H Or Hazmat Fees May Apply)

Andrei Sonnabend, Viola Spahn, Marlitt Stech, Anne Zemella, Christoph Stein, Stefan Kubick. Production of g protein-coupled receptors in an insect-based cell-free system. Biotechnology and Bioengineering. October 2017. Volume 114, Issue 10, pages 2328-2338.Peter Heusler, Stephanie Tardif, Didier Cussac. Agonist stimulation of human µ opioid receptors in a [³⁵S]GTPγS incorporation assay: observation of “bell-shaped” concentration-response relationships under conditions of strong receptor g protein coupling. Journal of Receptors and Signal Transduction. 2016. Volume 36, Issue 2, pages 158-166.Michael B Gatch, Alexey Kozlenkov, Ren-Qi Huang, Wenjuan Yang, Jacques D Nguyen, Javier Gonzalex-Maeso, Kenner C Rice, Charles P France, Glenn H Dillon, Michael J Forster, John A Schetz. The HIV Antiretroviral Drug Egavierenz has LSD-like Properties. Neuropsychopharmacology. May 2013.